Genomic technology is pivotal in the era of precision medicine. By sequencing a patient’s genome, doctors can identify specific genetic mutations driving the cancer. This information helps in selecting targeted therapies that are more effective and have fewer side effects compared to traditional treatments. Companies like 23andMe and Foundation Medicine are at the forefront of utilizing genomic data to improve cancer care.
